Covered recipient · General Payments record
YUHE HU
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Adult Health
General Payments · PY2021–2024
$1,184.65
- Reported across 46 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $614.17 | 19 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $313.51 | 6 |
| Novo Nordisk AS | $97.13 | 5 |
| Gilead Sciences, Inc. | $80.88 | 3 |
| Phathom Pharmaceuticals, Inc. | $47.91 | 2 |
| ABBVIE INC. | $29.64 | 1 |
| Merck Sharp & Dohme Corporation | $23.35 | 1 |
| ITI, Inc. | $21.75 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (19)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $29.64 | 06/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107364389 | CMS |
| Amgen Inc. | $125.00 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117281829 | CMS |
| Amgen Inc. | $24.53 | 06/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117281821 | CMS |
| Amgen Inc. | $13.38 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117281823 | CMS |
| Amgen Inc. | $125.00 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117281831 | CMS |
| Amgen Inc. | $6.52 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117281825 | CMS |
| Amgen Inc. | $19.08 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117281827 | CMS |
| Gilead Sciences, Inc. | $26.27 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133660386 | CMS |
| Gilead Sciences, Inc. | $27.39 | 08/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133660388 | CMS |
| Gilead Sciences, Inc. | $27.22 | 10/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133660390 | CMS |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $21.75 | 12/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143505491 | CMS |
| Merck Sharp & Dohme LLC | $23.35 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141605214 | CMS |
| Novo Nordisk Inc | $17.16 | 04/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100553991 | CMS |
| Novo Nordisk Inc | $19.26 | 06/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100277978 | CMS |
| Novo Nordisk Inc | $23.00 | 07/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100511757 | CMS |
| Novo Nordisk Inc | $19.70 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100384013 | CMS |
| Novo Nordisk Inc | $18.01 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100438817 | CMS |
| Phathom Pharmaceuticals, Inc. | $26.97 | 06/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151175453 | CMS |
| Phathom Pharmaceuticals, Inc. | $20.94 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151175455 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.